Physician

Internal Medicine

Stanislaw R. Burzynski practices Internal Medicine. He has 1 awards "Whos Who in Medicine and Healthcare". Stanislaw R. Burzynski is a published doctor and has 60 publications published. The lastest was: 'Urinary peptides in muscular dustrophy. 3. Studies on chick embryo fibroblast cultures.'

Publications

---

• The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainst...
• Targeted therapy with antineoplastons A10 and AS2-1 of high-grade, recurrent, and progressive brainstem glioma.
• Long-term survival of high-risk pediatric patients with primitive neuroectodermal tumors treated with antineoplastons A10 and AS2-1.
• Long-term survival and complete response of a patient with recurrent diffuse intrinsic brain stem glioblastoma multiforme.
• The present state of antineoplaston research (1).
• Phase II study of antineoplaston A10 and AS2-1 in children with recurrent and progressive multicentric glioma : a preliminary report.
• Aging: gene silencing or gene activation?
• Treatments for astrocytic tumors in children: current and emerging strategies.
• Phase II study of antineoplaston A10 and AS2-1 in patients with recurrent diffuse intrinsic brain stem glioma: a preliminary report.
• Gene silencing--a new theory of aging.
• Efficacy of antineoplastons A10 and AS2-1.
• Potential of antineoplastons in diseases of old age.
• The influence of antineoplaston A5 on particular subtypes of central dopaminergic receptors.
• Antineoplastons: the controversy continues.
• Cellular accumulation of antineoplaston AS21 in human hepatoma cells.
• The influence of antineoplaston A5 on the central dopaminergic structures.
• [The application of the photometry of negative printed chromatograms for quantitative determination of free amino acids in the blood of healthy people].
• [Quantitative determination of amino acids using photometry of negative printed chromatograms].
• [Free and bound amino acids in some edible mushrooms. 3. Determination of content of free and bound amino acids in edible mushrooms: Cantharellus cibarius Fr., Armilla...
• [Studies on the possibility of determination of mushroom species according to the composition of their amino acids].
• [Bound amino acids of some edible mushrooms].
• [Free amino acids of some edible mushrooms].
• Bound amino acids in serum of patients with chronic renal insufficiency.
• Free amino acids in serum of patients with chronic renal insufficiency.
• Investigations on unknown ninhydrin-reacting substances in human blood serum. I. Attempts at identification of 3 such substances.
• [Quantitative determination of amino acids in human blood with the use of our method and Beckman''s "amino acid analyser"].
• [Free amino acids in serum of obese children].
• Biologically active peptides in human urine. I. Isolation of a group of medium-sized peptides.
• Biologically active peptides in human urine: II. Effect on intestinal smooth muscle and heart.
• Altered methylation complex isozymes as selective targets for cancer chemotherapy.
• Chronic animal toxicity studies on antineoplaston A2.
• 3-Phenylacetylamino-2,6-piperidinedione, a naturally-occurring peptide analogue with apparent antineoplastic activity, may bind to DNA.
• Toxicology studies on antineoplaston A10 injections in cancer patients.
• Preclinical studies on antineoplaston A10 injections.
• Toxicology studies on antineoplaston AS2-1 injections in cancer patients.
• Toxicology studies on antineoplaston AS2-5 injections in cancer patients.
• Preclinical studies on antineoplaston AS2-1 and antineoplaston AS2-5.
• Stereochemical modelling studies of the interaction of antineoplaston A10 with DNA.
• Chemo-surveillance: a novel concept of the natural defence mechanism against cancer.
• Quantitative assay of plasma and urinary peptides as an aid for the evaluation of cancer patients undergoing antineoplaston therapy.
• N,N''-disubstituted L-isoglutamines as novel cancer chemotherapeutic agents.
• Chemoprevention by antineoplaston A10 of benzo(a)pyrene-induced pulmonary neoplasia.
• Pharmacokinetic study of radioactive antineoplaston A10 following oral administration in rats.
• Phase I clinical studies of antineoplaston A5 injections.
• Tissue culture and animal toxicity studies of antineoplaston A5.
• Phase I clinical studies of antineoplaston A3 injections.
• In vitro cancer growth inhibition and animal toxicity studies of antineoplaston A3.
• Initial clinical study with antineoplaston A2 injections in cancer patients with five years'' follow-up.
• Antineoplastons: history of the research (I).
• Treatment of hormonally refractory cancer of the prostate with antineoplaston AS2-1.
• Sequential analysis in subnanomolar amounts of peptides. Determination of the structure of a habituation-induced brain peptide (ameletin).
• Quantitative analysis of amino acids and peptides in the femtomolar range.
• Biological active peptides in human urine: III. Inhibitors of the growth of human leukemia, osteosarcoma, and HeLa cells.
• Antineoplastons: biochemical defense against cancer.
• Urinary peptides in muscular dustrophy. 3. Studies on chick embryo fibroblast cultures.
• [Antineoplastones (author''s transl)].
• Polypeptides that inhibit human breast cancer cell division.
• Joint ownership not always best answer.
• Antineoplaston A in cancer therapy. (I).

Doctors Specialties

---

• Internal Medicine

Accepted Insurances

---

Awards

---

• Whos Who in Medicine and Healthcare

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Alisha M. Acosta, MD This Doctor is OpenDoctor Recommended.
	Dr. Joanna-Grace M. Manzano, MD This Doctor is OpenDoctor Recommended.
	Dr. James P. Stanton, MD
	Dr. Carolyn L. Gardiner, MD This Doctor is OpenDoctor Recommended.
	Dr. Judi A. Shaw-Rice, MD
	Dr. Dave E. McNeill III, MD This Doctor is OpenDoctor Recommended.
	Dr. Lavone A. Smith, MD
	Dr. Teresa D. Kaldis, MD This Doctor is OpenDoctor Recommended.
	Dr. James M. Gray Jr., MD
	Dr. Rahana Sunesara, MD
	Dr. Rachel J. Zeider, MD This Doctor is OpenDoctor Recommended.
	Dr. Bernard A. Harris Jr., MD
	Dr. Vladimir Stanisic, MD This Doctor is OpenDoctor Recommended.
	Dr. Saadia Faiz, MD This Doctor is OpenDoctor Recommended.
	Dr. Ellen J. Fremion, MD This Doctor is OpenDoctor Recommended.
	Dr. Stephanie B. Mundy, MD This Doctor is OpenDoctor Recommended.
	Dr. Mona Elhaj Iversen, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog